510(k) Report

510(k) · Cleared

Cleared

QT Dispersion and T Wave Analysis Program (QT Guard Analysis System)

K981024510(k) TraditionalCleared Oct 6, 1998201-day review

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Marquette Medical Systems, Inc. · LOS (no longer in FDA’s product-code list)

Cleared on Oct 6, 1998 after a 201-day review. The FDA summary names its predicate without a number. 87 later devices descend from it.

Decided
Oct 6, 1998
Review
201 days
Product code
LOS
Recalls
None
Predicates
0

87 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2012: 3 descendants cleared2001: 1 descendant cleared2007: 3 descendants cleared2005: 3 descendants cleared2004: 1 descendant cleared2025: 6 descendants cleared2009: 2 descendants cleared2006: 1 descendant cleared2015: 7 descendants cleared2010: 2 descendants cleared2014: 4 descendants cleared2008: 2 descendants cleared2011: 2 descendants cleared2020: 6 descendants cleared2016: 7 descendants cleared2013: 3 descendants cleared2018: 2 descendants cleared2017: 7 descendants cleared2022: 4 descendants cleared2021: 4 descendants cleared2019: 4 descendants cleared2026: 4 descendants cleared2023: 7 descendants cleared2024: 2 descendants cleared1995200020052010201520202025
  1. This deviceK981024 QT Dispersion and T Wave Analysis Program (QT Guard Analysis System)Marquette Medical Systems, Inc. · 1998
  2. Descendant · cites it directly · 85 of its ownK010949 2010 Plus Holter for WindowsAgilent Technologies · 2001
  3. Descendant · 2 generations on · 46 of its ownK042108 Vista PlusNovacor · 2005
  4. Descendant · 3 generations on · 40 of its ownK071641 Reveal XT; Insertable Cardiac Monitor (Model 9529), Patient…Medtronic, Inc. · 2007
  5. Descendant · 3 generations on · 30 of its ownK071655 Reveal DX Insertable Cardiac Monitor, Reveal Patient Assistant…Medtronic, Inc. · 2007
  6. Descendant · 4 generations on · 28 of its ownK082475 Reveal XT Insertable Cardiac Monitor, Model 9529, Revel DX…Medtronic, Inc. · 2008

Showing 5 of 87 descendants. See all descendants

Descendants cleared per year

2001: 12004: 12005: 32006: 12007: 32008: 22009: 22010: 22011: 22012: 32013: 32014: 42015: 72016: 72017: 72018: 22019: 42020: 62021: 42022: 42023: 72024: 22025: 62026: 4
2001high 7 (2015) · low 0 (2002)2026

Most influential descendants

Showing 5 of 87 · See all
  • K0109492010 Plus Holter for WindowsAgilent Technologies · 2001 · cites it directly85descendants
  • K042108Vista PlusNovacor · 2005 · 2 generations on46descendants
  • K071641Reveal XT; Insertable Cardiac Monitor (Model 9529), Patient Assistant (Model 9539)Medtronic, Inc. · 2007 · 3 generations on40descendants
  • K071655Reveal DX Insertable Cardiac Monitor, Reveal Patient Assistant, Model (S) 9528,9538Medtronic, Inc. · 2007 · 3 generations on30descendants
  • K082475Reveal XT Insertable Cardiac Monitor, Model 9529, Revel DX Insertable Cardiac Monitor…Medtronic, Inc. · 2008 · 4 generations on28descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K981024QT Dispersion and T Wave Analysis Program (QT Guard Analysis System)Marquette Medical Systems, Inc.1998—
+1K0109492010 Plus Holter for WindowsAgilent Technologies2001—
+2K042108Vista PlusNovacor2005—
+3K071641Reveal XT; Insertable Cardiac Monitor (Model 9529), Patient Assistant (Model…Medtronic, Inc.2007—
+3K071655Reveal DX Insertable Cardiac Monitor, Reveal Patient Assistant, Model (S)…Medtronic, Inc.2007—
+4K082475Reveal XT Insertable Cardiac Monitor, Model 9529, Revel DX Insertable Cardiac…Medtronic, Inc.2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200110
200410
200530
200610
200730
200820
200920
201020
201120
201230
201330
201440
201570
201670
201770
201820
201940
202060
202140
202240
202370
202420
202560
202640
FIG. 1 — Lineage of K981024, 1998–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LOS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Marquette 12SL Analysis Program
Named without a submission number
—

What descends from it? (87)

See all 87

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K0109492010 Plus Holter for WindowsAgilent Technologies200185
K120770QT Guard Plus Analysis SystemGe Medical Systems Information Technologies20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K010949 (Agilent Technologies, 2001) has gone furthest, with 85 descendants of its own.

What is it indicated for?

QT Guard Analysis System is intended to be used in a hospital or clinic environment by competent health professionals. QT Guard Analysis System is intended to perform the analysis of simultaneously acquired 12-lead ECG for obtaining the measurements of QT interval dispersion and T wave complexity. QT-Guard Analysis Program is intended to provide only the measurements of the QT dispersion and T wave complexity and is not intended to produce any…

Read the full statement (130 words)

QT Guard Analysis System is intended to be used in a hospital or clinic environment by competent health professionals.

QT Guard Analysis System is intended to perform the analysis of simultaneously acquired 12-lead ECG for obtaining the measurements of QT interval dispersion and T wave complexity.

QT-Guard Analysis Program is intended to provide only the measurements of the QT dispersion and T wave complexity and is not intended to produce any interpretation of those measurements or diagnosis.

The QT dispersion and T wave complexity measurements produced by QT Guard Analysis System are intended to be used by qualified personnel in evaluating the patient in conjunction with patient's clinical history, symptoms, other diagnostic tests, as well as the professional’s clinical judgment.

QT Guard Analysis System is intended for adult patient populations.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K981024: QT Dispersion and T Wave Analysis Program (QT Guard Analysis System).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K981024

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026